Skip to main content
SpringerLink
Log in

Afatinib

Skin toxicity

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ljujic K, et al. Is there a difference in the mechanisms of development of skin toxicity between EGFR TKIs: A case presentation of severe skin adverse event during treatment with afitinib. Libri Oncologici 51 (Suppl. 2): 60 abstr. P16, Jan 2023 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Afatinib. Reactions Weekly 1986, 26 (2023). https://doi.org/10.1007/s40278-023-51331-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-51331-6

Search

Navigation